Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ibuprofen Lysinate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Gamma Scintigraphy Study to Investigate Tablet Disintegration in Healthy Volunteers.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 13, 2018
Lead Product(s) : Ibuprofen Lysinate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ibuprofen Lysinate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Simbec Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Ibuprofen and Paracetamol Pharmacokinetic Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 22, 2015
Lead Product(s) : Ibuprofen Lysinate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Simbec Research
Deal Size : Inapplicable
Deal Type : Inapplicable